GE HealthCare acquires Sofie Biosciences for $945M to expand radiopharma

GE HealthCare agreed to acquire Sofie Biosciences, a maker of radioactive imaging products, for $945M in cash from Trilantic North America. The deal signals consolidation in the radiopharmaceuticals market, a high-growth niche. Financial impact on GE HealthCare is modest relative to its size, but the strategic pivot is notable.